Progress and challenges in transplantation of human pluripotent stem cell derived cardiomyocytes for cardiac therapy

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Myocardial infarction and heart failure are primary global mortality causes.
• Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) show potential for myocardial regeneration.
• Current treatments for cardiac damage have limitations.

Purpose of the Study:

• To review advancements in hPSC-CMs for cardiac repair.
• To examine differentiation, manufacturing, delivery, and clinical studies of hPSC-CMs.
• To discuss challenges and future directions for hPSC-CM clinical translation.

Main Methods:

• Literature review of hPSC-CM research.
• Analysis of differentiation and scale-up techniques.
• Evaluation of preclinical and clinical study data.
• Examination of repair mechanisms and challenges.

Main Results:

• Significant progress in hPSC-CM differentiation and manufacturing.
• Development of various delivery strategies for hPSC-CMs.
• Insights from preclinical models and early clinical trials.
• Identification of key challenges in hPSC-CM therapy.

Conclusions:

• hPSC-CMs represent a viable therapeutic strategy for cardiac regeneration.
• Further research is needed to overcome manufacturing and delivery hurdles.
• Clinical translation of hPSC-CM therapies is progressing but requires continued effort.